Small cell carcinoma of the prostate: Three case reports and a literature review

Urological Science

Volumn 24, Issue 4, 2013, Pages 131-135

  Huang, I Shen ^a,b   Huang, William J S ^a,b   Lin, Alex T L ^a,b   Chen, Kuang Kuo ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; Prostate; Small cell carcinoma

Indexed keywords

BICALUTAMIDE; CD56 ANTIGEN; CHROMOGRANIN; CISPLATIN; CYPROTERONE ACETATE; CYTOKERATIN; ETOPOSIDE; FLUTAMIDE; GOSERELIN; PROSTATE SPECIFIC ANTIGEN; SYNAPTOPHYSIN; TRIPTORELIN;

ABDOMINAL RADIOGRAPHY; ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE METASTASIS; BONE PAIN; BRAIN METASTASIS; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER SURGERY; LIMB WEAKNESS; LUNG METASTASIS; LYMPHADENOPATHY; MALE; MICTURITION DISORDER; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE SMALL CELL CARCINOMA; PROTEIN BLOOD LEVEL; SMALL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE RETENTION; VERY ELDERLY; WHOLE BODY IMAGING;

EID: 84889589288     PISSN: 18795226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urols.2013.05.003     Document Type: Article

References (11)

1. Wang W., Epstein J.I. Small cell carcinoma of the prostate - A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008, 32:65-71.
2. Deorah S., Rao M.B., Raman R., Gaitonde K., Donovan J.F. Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study. BJU Int 2012, 109:824-830.
3. Abbas F., Civantos F., Benedetto P., Soloway M.S. Small cell carcinoma of the bladder and prostate. Urology 1995, 46:617-630.
4. Li A.F., Hsu H.S., Hsu C.Y., Li A.C., Li W.Y., Liang W.Y., et al. A20-year retrospective study of small-cell carcinomas in Taiwan. JSurg Oncol 2010, 102:497-502.
5. di Sant'Agnese P.A., Cockett A.T. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996, 78:357-361.
6. Oesterling J.E., Hauzeur C.G., Farrow G.M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. JUrol 1992, 147:804-807.
7. Helpap B., Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999, 434:385-391.
8. Hirano D., Okada Y., Minei S., Takimoto Y., Nemoto N. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol 2004, 45:586-592. discussion 92.
9. Yao J.L., Madeb R., Bourne P., Lei J., Yang X., Tickoo S., et al. Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol 2006, 30:705-712.
10. Aoki H., Ishidoya S., Ito A., Endoh M., Shimazui T., Arai Y. Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Int J Urol 2006, 13:1254-1258.
11. Mackey J.R., Au H.J., Hugh J., Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. JUrol 1998, 159:1624-1629.